Viatris, Inc. (VTRS)
13.20
-0.30
(-2.22%)
USD |
NASDAQ |
Mar 20, 16:00
13.29
+0.09
(+0.68%)
After-Hours: 20:00
Viatris Research and Development Expense (Quarterly) : 259.80M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Baxter International, Inc. | 116.00M |
| Pfizer Inc. | 3.133B |
| Dentsply Sirona, Inc. | 40.00M |
| Theravance Biopharma, Inc. | 7.362M |
| Artivion, Inc. | 9.122M |